Michael J. Baldwin

Associate
Michael focuses his practice on intellectual property litigation matters.
AFS Default Fox Headshot

Michael is passionate about all things patent. He has experience in litigating complex intellection property issues in district courts and agencies, including post-grant proceedings. Michael’s experience focuses primarily on clients in the life science and technology sectors, including pharmaceuticals, contract and licensing disputes, and medical devices.

While in law school, Michael served as a legal intern for the Hon. Robert R. Rigsby of the District of Columbia Superior Court. He also was a staff editor for the AIPLA Quarterly Journal.

Publications, Presentations & Recognitions

Publications

  • “Just How Similar Must Competing Marks Be to Survive Dismissal?” National Law Review (Oct. 5, 2023)
  • “No Two Ways About It: No Disparagement ≠ Teaching Away, Free Samples ≠ Commercial Success,” National Law Review (Aug. 31, 2023)
  • “A Textbook Example: Single Online Sale Does Not a Minimum Contact Make,” National Law Review (Aug. 10, 2023)
  • “If at First You DuPont Succeed, Try a Different Factor,” National Law Review (Jul. 13, 2023)
  • “District Court Finding Doesn’t Preclude PTAB Proceeding,” National Law Review (Jun. 18, 2023)
  • “Allegations in Complaint Prevail over Statements in Exhibit,” National Law Review (Apr. 20, 2023)
  • “Swing and a Miss: Failed Interferences Don’t Affect Later Ones,” National Law Review (Jan. 19, 2023)
  • “Burdens Can’t Be Avoided No Matter How They’re Dressed Up,” National Law Review (Jan. 5, 2023)
  • “The Board Is Back in Town: Arthrex Can’t Save Untimely Motions to Terminate,” National Law Review (Sep. 29, 2022)
  • “PTO Can and Should Use Alice/Mayo Framework to Assess Eligibility,” National Law Review (Sep. 1, 2022)
  • “Stormy Weather Ahead: Lack of Causation Evidence Rains Out Appeal,” National Law Review (Jul. 14, 2022)
  • “Claim Construction and Jurisdictional Discovery Are More Than Skin Deep,” National Law Review (Aug. 31, 2022)